![Matthew Del Giudice](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: - $ in data 31/08/2026
Dr. Matthew P.
Del Giudice, MD, is an Independent Director at Telomir Pharmaceuticals, Inc. and an Independent Director at MIRA Pharmaceuticals, Inc. He is on the Board of Directors at Telomir Pharmaceuticals, Inc. and MIRA Pharmaceuticals, Inc. Dr. Del Giudice was previously employed as a Head-General Overnight Emergency Radiologist by The Cleveland Clinic Foundation.
He received his undergraduate degree from the University of Illinois At Urbana–Champaign and a doctorate degree from Stritch School of Medicine.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 21/07/2026 | 0 ( -.--% ) | - $ | 31/08/2026 | |
| 21/07/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| MIRA PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 13/03/2024 |
| TELOMIR PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 12/08/2024 |
| Società | Posizione | Fine |
|---|---|---|
The Cleveland Clinic Foundation
 The Cleveland Clinic Foundation Medical/Nursing ServicesHealth Services Provides healthcare services | Corporate Officer/Principal | 01/05/2022 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
The Cleveland Clinic Foundation
The Cleveland Clinic Foundation Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Stritch School of Medicine
 Stritch School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Illinois At Urbana–Champaign
 University of Illinois At Urbana–Champaign Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MIRA Pharmaceuticals, Inc.
 MIRA Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Develops and sells new molecular synthetic THC for the treatment of adult patients with anxiety and cognitive decline | Health Technology |
Telomir Pharmaceuticals, Inc.
 Telomir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops a novel small molecule as the first regulator of telomere length and genomic stability | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
